-
公开(公告)号:WO2011022393A3
公开(公告)日:2011-06-23
申请号:PCT/US2010045752
申请日:2010-08-17
申请人: BRIGHAM & WOMENS HOSPITAL , COHEN DAVID , WAGLE NEIL , CUNY GREGORY D , XIAN JUN , GLICKSMAN MARCIE , STEIN ROSS L , SHISHOVA EKATERINA Y
发明人: COHEN DAVID , WAGLE NEIL , CUNY GREGORY D , XIAN JUN , GLICKSMAN MARCIE , STEIN ROSS L , SHISHOVA EKATERINA Y
IPC分类号: C07D239/32 , A61K31/4402 , A61K31/505 , A61P3/04 , C07D213/60
CPC分类号: C07D239/69 , A61K31/44 , A61K31/505 , C07C311/21 , C07D213/60 , C07D213/76 , C07D213/89 , C07D217/22 , C07D239/32 , C07D239/42
摘要: This invention relates to compounds of Formulas I, II, and III, and their use as inhibitors of phosphatidylcholine transfer protein (PC-TP). The invention further relates to pharmaceutical compositions and methods of treatment of disorders related to the inhibition of PC-TP using the compounds of Formulas I, II, and III. Such disorders include obesity and disorders associated with obesity.
摘要翻译: 本发明涉及式I,II和III的化合物及其作为磷脂酰胆碱转移蛋白(PC-TP)抑制剂的用途。 本发明还涉及使用式I,II和III的化合物治疗与PC-TP的抑制相关的病症的药物组合物和方法。 这种疾病包括肥胖症和与肥胖相关的疾病。
-
公开(公告)号:WO2011022393A2
公开(公告)日:2011-02-24
申请号:PCT/US2010/045752
申请日:2010-08-17
申请人: THE BRIGHAM AND WOMEN'S HOSPITAL, INC. , COHEN, David , WAGLE, Neil , CUNY, Gregory D. , XIAN, Jun , GLICKSMAN, Marcie , STEIN, Ross L. , SHISHOVA, Ekaterina Y.
发明人: COHEN, David , WAGLE, Neil , CUNY, Gregory D. , XIAN, Jun , GLICKSMAN, Marcie , STEIN, Ross L. , SHISHOVA, Ekaterina Y.
IPC分类号: C07D239/32 , C07D213/60 , A61K31/505 , A61K31/4402 , A61P3/04
CPC分类号: C07D239/69 , A61K31/44 , A61K31/505 , C07C311/21 , C07D213/60 , C07D213/76 , C07D213/89 , C07D217/22 , C07D239/32 , C07D239/42
摘要: This invention relates to compounds of Formulas I, II, and III, and their use as inhibitors of phosphatidylcholine transfer protein (PC-TP). The invention further relates to pharmaceutical compositions and methods of treatment of disorders related to the inhibition of PC-TP using the compounds of Formulas I, II, and III. Such disorders include obesity and disorders associated with obesity.
摘要翻译: 本发明涉及式I,II和III的化合物以及它们作为磷脂酰胆碱转移蛋白(PC-TP)的抑制剂的用途。 本发明还涉及使用式I,II和III的化合物治疗与抑制PC-TP有关的病症的药物组合物和方法。 这些疾病包括肥胖和与肥胖相关的疾病。 p>
-